• Home
• Insights
  • All articles
    • A seasoned consultant and life sciences CEO joins Genioo as Senior Client Partner
    • TechOps transformation drives product launch and $1bn+ P&L impact
    • Building a robust Launch Readiness capability
    • Inventory management optimization
    • Codifying product launch preparations
    • Securing supply to protect patients
    • Reimagining global procurement to drive innovation and value
    • Global Supply Chain transformation readiness to deliver >$1bn savings
    • Applying design to cost to radically cut production cost and time for a groundbreaking cell therapy
    • TechOps transformation in generics delivers $200m+ savings
    • Unlocking hundreds of millions USD trapped in redundant POs
    • A Procurement partnership with IT identifies a $4m+ spend reduction and deepens supplier relationships
    • Global supply chain improvements save millions and elevate quality and service for customers
    • An engagement blueprint helps relaunch a drug and retain 40% market share
    • Celebrating Diversity at Genioo
    • A strong start to the new year with a new President for Genioo
    • Reinforcing Genioo’s purpose and performance with a new CFO and Board Advisor
    • Dare To Dream, Dare To Succeed
    • From vision to value
    • Defy Convention To Deliver Outstanding Results
    • Frederic Brunner, Genioo's CEO and Founder, recognized as a Global Leader in Consulting by Consulting Magazine
    • Genioo Europe Reconnect
    • Summer Academy 2022 Highlights
    • Faster, Better, Cheaper
    • Changing gears
    • When cost is king
    • The State of Independents
    • A Healthy Approach to Drive Diversity and Inclusion in Clinical Trials
    • Genioo Launches Podcast Series featuring interviews with Life Sciences Leaders
    • Enhancing diversity & inclusion in clinical trials
    • Interview with Laurent Attias, SVP Corporate Strategy, BD&L and M&A at Alcon
    • Are you realizing the full value of your portfolio companies?
    • Interview with David Murray, CFO, BVI Medical
    • Interview with Markus Sieger, CEO of Polpharma Group
    • Interview with Peter Goldschmidt, CEO of STADA Group
    • Laurent Attias, SVP Corporate Strategy, BD&L and M&A at Alcon
    • Interview with Julie Kim, President U.S. Business Unit, Takeda
    • What is Genioo's vision?
    • Julie Kim, President, U.S. Business Unit of Takeda
    • Peter Goldschmidt, CEO of STADA Group
    • David Murray, CFO of BVI Medical
    • Markus Sieger, CEO of Polpharma
    • Genioo Summer Academy 2021 - highlights video
    • Klosterfrau and Genioo ERP Implementation - Project Testimonial
    • What does Genioo do?
    • Independent professionals - Interview with Dominique, a member of our Independent Professional Community
    • Independent Professionals - What do we look for?
    • What is the Top Team Alignment program?
    • What is the Success Planning program?
    • Why is Genioo different?
    • Genioo Careers - What makes Genioo different?
    • Project Testimonial: Klosterfrau ERP implementation
    • Supporting Organizational Transition: Klosterfrau ERP Implementation
    • Adopting a one-team approach
    • Genioo Careers - Where we come from
    • Genioo Careers - We are looking for the RIGHT people
    • Consulting firm Genioo welcomes Sarah Bond as Head of Freelance Talent
    • Genioo opens new office in Berlin
    • Remote control: Managing projects in a virtual world
    • Genioo sponsors PEI Operating Partners Forum Europe
    • Why most projects fail before they even start
    • We succeed together
    • Production Strategy: Defining a 20-year API Production Strategy for a Pharmaceutical Company
    • Supply Chain: Enabling a Global Pharmaceutical Company to Become an Industry Leader Through End-to-End Streamlining of its Supply Chain
    • Supply Chain: Establishing Transformation Program with Organization-Wide Alignment and Ownership for a Large Pharmaceutical Company
    • Transformation Program: SI&OP Transformation for Global Specialty Chemicals Company to Address Supply Chain Issues
    • Transformation Program: Identifying COGS Reduction Opportunities in Top 20 Molecules for a Global Leader in Generic and Biosimilars
    • TechOps Functions: Supporting a Global Pharmaceutical Company in Integrating Multiple TechOps Organizations into One Global Division
    • Top Team Alignment: Three to Five Year Strategy Workshop for a Technical Organization
    • Productivity Program: Unlocking USD 500m to Fuel Future Growth
    • Global Transformation: Supporting a Leading Life Sciences Company in Global Transformation Program to Generate 200m USD in Annual Savings
    • Productivity Services: Accelerating Results for a PE-owned Life Sciences Company Through Improved Transparency and Decision-making
    • TechOps Transforation: Supporting a Global Pharmaceutical Company through TechOps Transfromation Resulting in 20% Core COGS Improvement
    • Digital Functions: Supporting Digital Go-to-Market Model Ideation and Planning Workshop for a Leading Pharmaceutical Company
    • Digital Partnership: Executing Partnership Rollout for a Global Pharmaceutical Company to Better Reach HCPs Through Digital Sales Channels
    • Digital Strategy: Data-driven Replenishment Optimization (DDRO) Solution Pilot Yielding a EUR 20m Business Case in 12 Weeks
    • Post Merger Integration: Management of All Integration Activities of a Digital Visualization Company Acquired by a Medical Device Firm
    • Commercial Services: Managing Cross-Functional PMI Activities of an Early Stage Device Company
    • Optimizing and Aligning Operations: Developing an Operating Model ”Playbook” for the CMO Organization of a Large Pharmaceutical Company Following a Large Merger
    • Top Team Alignment: High-Impact Change Management Workshops for Large Pharmaceutical Company
    • Employee Enablement: Designing an Integrated "Learning Strategy" with Underlying Learning Platform for a Global Pharmaceutical Company
    • Success Planning & Transformation Program: Defining Future Organizational IT Capabilities and Workforce Transformation Program ro a Global Pharmaceutical Company
    • Commercial Strategy: Refreshing a Medical Device Firm’s China Strategy and Roadmap with Focus on New Growth Opportunities
    • Global Corporate Strategy: Developing a Corporate Strategy for a Biotech with a Focus on Accelerating Investments and Footprint in China
    • R&D Functions: Performing Biosimilars Landscape Study for a Leading Generics Company to Assess Risks to Growth Projections
    • Business Development & Licensing (BD&L): Supporting a Large Medical Device Organization in BD&L Assessment of a Potential Acquisition Target
    • Commercial Strategy Redefinition: Establishing a Strategic Plan to Transform the Commercial and Manufacturing Strategy of a Leading Biopharma CDMO
    • Transformation Program: Increasing Scientific Rigor, Cost Reduction and Spend Transparency for Local Clinical Trials
    • Innovative Solution: Increasing Compliance and Empowering Medical Affairs
    • Productivity Evolution: Improving Cross-Functional Stage Gate Product Development Process for a Medical Device Company
    • R&D: Strategic R&D Reorganization of Pre-Clinical Development Functions to a More Decentralized Operating Model
    • R&D Transformation: Supporting an 18-month Transformation to Reduce High Overhead of Divested Project Portfolio
    • Commercial Functions: Managing Risk and Compliance Remediation of Multiple FDA-Certified Sites for Production of Sterilized Products
    • Procurement Strategy: Defining a Procurement Roadmap for a Biotech Start-up with a Virtual Business Model
    • Global Management: Establishing Spare Parts Management Program Across 35 Production Sites Resulting in Annual Savings of >USD 50m
    • Procurement and Supply Chain: Establishing Global Centers of Excellence Specializing in Procurement and Supply Chain Generating Sourcing Savings of USD 120m
    • Commercial Strategy: Supporting Global Car-T Biotech Company to Commercialize their Technology in Partnership with Leading Pharmaceutical Company and CMOs
    • Market Strategy: Defining and Embedding Global Market Access Excellence Across the Organization of a Large Pharmaceutical Company
    • Commercial Structure: Creating Launch Plan and Commercial Structure for a Recently Approved Rare Disease Gene Therapy Drug
    • Launch Program: Managing the Launch of a Next-Generation OTC Treatment Product in Four Markets
    • Success Planning: Standardizing and Streamlining a Medical Device Firm's Brand Planning Process
    • The surprising links between M&A trends and Digital focus in Pharma
    • Procurement Transformation: Partnering to Procure Value
    • Genioo Expertise Expands Beyond Borders for Ambitious Clients with Big Ideas!
    • With profitability under the microscope, how can life sciences fight back?
  • Blog
  • Whitepapers
    • When cost is king
    • The surprising links between M&A trends and Digital focus in Pharma
  • Case studies
    • TechOps transformation drives product launch and $1bn+ P&L impact
    • Building a robust Launch Readiness capability
    • Inventory management optimization
    • Codifying product launch preparations
    • Securing supply to protect patients
    • Reimagining global procurement to drive innovation and value
    • Global Supply Chain transformation readiness to deliver >$1bn savings
    • Applying design to cost to radically cut production cost and time for a groundbreaking cell therapy
    • TechOps transformation in generics delivers $200m+ savings
    • Unlocking hundreds of millions USD trapped in redundant POs
    • A Procurement partnership with IT identifies a $4m+ spend reduction and deepens supplier relationships
    • Global supply chain improvements save millions and elevate quality and service for customers
    • An engagement blueprint helps relaunch a drug and retain 40% market share
    • A Healthy Approach to Drive Diversity and Inclusion in Clinical Trials
    • Supporting Organizational Transition: Klosterfrau ERP Implementation
    • Procurement Transformation: Partnering to Procure Value
  • Projects
  • Project
    • Production Strategy: Defining a 20-year API Production Strategy for a Pharmaceutical Company
    • Supply Chain: Enabling a Global Pharmaceutical Company to Become an Industry Leader Through End-to-End Streamlining of its Supply Chain
    • Supply Chain: Establishing Transformation Program with Organization-Wide Alignment and Ownership for a Large Pharmaceutical Company
    • Transformation Program: SI&OP Transformation for Global Specialty Chemicals Company to Address Supply Chain Issues
    • Transformation Program: Identifying COGS Reduction Opportunities in Top 20 Molecules for a Global Leader in Generic and Biosimilars
    • TechOps Functions: Supporting a Global Pharmaceutical Company in Integrating Multiple TechOps Organizations into One Global Division
    • Top Team Alignment: Three to Five Year Strategy Workshop for a Technical Organization
    • Productivity Program: Unlocking USD 500m to Fuel Future Growth
    • Global Transformation: Supporting a Leading Life Sciences Company in Global Transformation Program to Generate 200m USD in Annual Savings
    • Productivity Services: Accelerating Results for a PE-owned Life Sciences Company Through Improved Transparency and Decision-making
    • TechOps Transforation: Supporting a Global Pharmaceutical Company through TechOps Transfromation Resulting in 20% Core COGS Improvement
    • Digital Functions: Supporting Digital Go-to-Market Model Ideation and Planning Workshop for a Leading Pharmaceutical Company
    • Digital Partnership: Executing Partnership Rollout for a Global Pharmaceutical Company to Better Reach HCPs Through Digital Sales Channels
    • Digital Strategy: Data-driven Replenishment Optimization (DDRO) Solution Pilot Yielding a EUR 20m Business Case in 12 Weeks
    • Post Merger Integration: Management of All Integration Activities of a Digital Visualization Company Acquired by a Medical Device Firm
    • Commercial Services: Managing Cross-Functional PMI Activities of an Early Stage Device Company
    • Optimizing and Aligning Operations: Developing an Operating Model ”Playbook” for the CMO Organization of a Large Pharmaceutical Company Following a Large Merger
    • Top Team Alignment: High-Impact Change Management Workshops for Large Pharmaceutical Company
    • Employee Enablement: Designing an Integrated "Learning Strategy" with Underlying Learning Platform for a Global Pharmaceutical Company
    • Success Planning & Transformation Program: Defining Future Organizational IT Capabilities and Workforce Transformation Program ro a Global Pharmaceutical Company
    • Commercial Strategy: Refreshing a Medical Device Firm’s China Strategy and Roadmap with Focus on New Growth Opportunities
    • Global Corporate Strategy: Developing a Corporate Strategy for a Biotech with a Focus on Accelerating Investments and Footprint in China
    • R&D Functions: Performing Biosimilars Landscape Study for a Leading Generics Company to Assess Risks to Growth Projections
    • Business Development & Licensing (BD&L): Supporting a Large Medical Device Organization in BD&L Assessment of a Potential Acquisition Target
    • Commercial Strategy Redefinition: Establishing a Strategic Plan to Transform the Commercial and Manufacturing Strategy of a Leading Biopharma CDMO
    • Transformation Program: Increasing Scientific Rigor, Cost Reduction and Spend Transparency for Local Clinical Trials
    • Innovative Solution: Increasing Compliance and Empowering Medical Affairs
    • Productivity Evolution: Improving Cross-Functional Stage Gate Product Development Process for a Medical Device Company
    • R&D: Strategic R&D Reorganization of Pre-Clinical Development Functions to a More Decentralized Operating Model
    • R&D Transformation: Supporting an 18-month Transformation to Reduce High Overhead of Divested Project Portfolio
    • Commercial Functions: Managing Risk and Compliance Remediation of Multiple FDA-Certified Sites for Production of Sterilized Products
    • Procurement Strategy: Defining a Procurement Roadmap for a Biotech Start-up with a Virtual Business Model
    • Global Management: Establishing Spare Parts Management Program Across 35 Production Sites Resulting in Annual Savings of >USD 50m
    • Procurement and Supply Chain: Establishing Global Centers of Excellence Specializing in Procurement and Supply Chain Generating Sourcing Savings of USD 120m
    • Commercial Strategy: Supporting Global Car-T Biotech Company to Commercialize their Technology in Partnership with Leading Pharmaceutical Company and CMOs
    • Market Strategy: Defining and Embedding Global Market Access Excellence Across the Organization of a Large Pharmaceutical Company
    • Commercial Structure: Creating Launch Plan and Commercial Structure for a Recently Approved Rare Disease Gene Therapy Drug
    • Launch Program: Managing the Launch of a Next-Generation OTC Treatment Product in Four Markets
    • Success Planning: Standardizing and Streamlining a Medical Device Firm's Brand Planning Process
  • Articles
    • Dare To Dream, Dare To Succeed
    • From vision to value
    • Defy Convention To Deliver Outstanding Results
    • Faster, Better, Cheaper
    • Changing gears
    • The State of Independents
    • Enhancing diversity & inclusion in clinical trials
    • Are you realizing the full value of your portfolio companies?
    • Adopting a one-team approach
    • Remote control: Managing projects in a virtual world
    • Why most projects fail before they even start
    • With profitability under the microscope, how can life sciences fight back?
  • Interviews
    • Project Testimonial: Klosterfrau ERP implementation
    • We succeed together
  • Videos
  • The WOW Series
    • Interview with Laurent Attias, SVP Corporate Strategy, BD&L and M&A at Alcon
    • Interview with David Murray, CFO, BVI Medical
    • Interview with Markus Sieger, CEO of Polpharma Group
    • Interview with Peter Goldschmidt, CEO of STADA Group
    • Laurent Attias, SVP Corporate Strategy, BD&L and M&A at Alcon
    • Interview with Julie Kim, President U.S. Business Unit, Takeda
    • Julie Kim, President, U.S. Business Unit of Takeda
    • Peter Goldschmidt, CEO of STADA Group
    • David Murray, CFO of BVI Medical
    • Markus Sieger, CEO of Polpharma
  • Company news
    • A seasoned consultant and life sciences CEO joins Genioo as Senior Client Partner
    • A strong start to the new year with a new President for Genioo
    • Reinforcing Genioo’s purpose and performance with a new CFO and Board Advisor
    • Frederic Brunner, Genioo's CEO and Founder, recognized as a Global Leader in Consulting by Consulting Magazine
    • Genioo Launches Podcast Series featuring interviews with Life Sciences Leaders
    • Consulting firm Genioo welcomes Sarah Bond as Head of Freelance Talent
    • Genioo opens new office in Berlin
    • Genioo sponsors PEI Operating Partners Forum Europe
    • Genioo Expertise Expands Beyond Borders for Ambitious Clients with Big Ideas!
  • Series
    • Celebrating Diversity at Genioo
• About Us
  • Our leadership team
  • Our Culture & Values
  • Get to know us
  • Celebrating International Women's Day
• Contact
  • Boston
  • Zug
  • New York
  • Berlin
  • London
• News & Events
  • Events
    • Webinars
      • The post - COVID playbook
    • All events
      • The post - COVID playbook
  • News
• Search
• Sitemap
• Locations
  • New York
  • Frankfurt
  • Boston
  • Zug (HQ)
  • Berlin
  • London
  • Dallas
• Terms and conditions
  • Cookie policy
  • Privacy policy
• Redirect
• The WOW series
  • The WOW series - Promo with speakers
• The Genioo Way
  • Transforming Transformation
  • Our unique process
  • One team approach
  • Who it works for